FDA recall D-1340-2022

Product

Launch Sequence Euphoria Capsules, 10- count tins, ASIN B08ZJX4V9J, UPC Code 661020846864.

Reason for recall

Marketed Without An Approved NDA/ANDA: Unapproved Drug based on label claims.

Distribution

The product was distributed nationwide in the USA and Canada.

Key facts

Status

Terminated

Initiation date

2022-06-27

Report date

2022-07-27

Termination date

2023-02-08

Voluntary/Mandated

Voluntary: Firm initiated

Location

Hauppauge, NY, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1340-2022